TRV GP III, LLC - Q3 2021 holdings

$527 Million is the total value of TRV GP III, LLC's 7 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .

 Value Shares↓ Weighting
RVMD  REVOLUTION MEDICINES, INC.$151,966,000
-13.3%
5,524,0310.0%28.85%
-5.8%
FULC SellFULCRUM THERAPEUTICS, INC.$139,984,000
+124.0%
4,962,202
-16.8%
26.57%
+143.6%
PLRX  PLIANT THERAPEUTICS, INC.$98,565,000
-42.0%
5,839,1600.0%18.71%
-37.0%
NRIX SellNURIX THERAPEUTICS, INC.$72,580,000
-20.1%
2,422,549
-29.2%
13.78%
-13.1%
DBTX  DECIBEL THERAPEUTICS, INC.$24,207,000
-10.3%
3,139,6850.0%4.60%
-2.5%
JNCE  JOUNCE THERAPEUTICS, INC.$22,652,000
+9.3%
3,048,7800.0%4.30%
+18.8%
VYGR  VOYAGER THERAPEUTICS, INC.$16,809,000
-36.3%
6,391,1760.0%3.19%
-30.8%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Mark Levin #1
  • Kevin P. Starr #2
  • Robert I. Tepper #3
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VOYAGER THERAPEUTICS, INC.22Q1 202374.0%
JOUNCE THERAPEUTICS, INC.20Q3 202224.5%
PLIANT THERAPEUTICS, INC.14Q3 2023100.0%
FULCRUM THERAPEUTICS, INC.14Q4 202243.8%
REVOLUTION MEDICINES, INC.12Q4 202253.8%
DECIBEL THERAPEUTICS, INC.10Q2 202366.3%
NEON THERAPEUTICS, INC.8Q1 202041.1%
NURIX THERAPEUTICS, INC.8Q2 202217.7%
RELAY THERAPEUTICS, INC.2Q4 202037.7%
MYOKARDIA, INC.2Q1 201822.1%

View TRV GP III, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR2023-05-12
13F-HR2023-02-14
42023-02-06
42023-02-01
42023-01-31
42023-01-26
42023-01-24

View TRV GP III, LLC's complete filings history.

Compare quarters

Export TRV GP III, LLC's holdings